Xero Ltd's stock soared 7.76% during intraday trading on Thursday, as positive analyst commentary fueled investor optimism.
UBS analysts reiterated their buy rating on Xero, highlighting several potential catalysts for the stock to rerate. They pointed to the accounting-software provider's upcoming fiscal 2027 guidance, expected next month, and any positive news regarding growth at its Melio payments unit as key factors that could spark the stock.
The analysts added that the market may not be fully appreciating Xero's defensiveness against the threat of AI disruption or the value embedded in its Melio business unit, contributing to the positive sentiment driving the share price higher.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.